
A recent example of this approach is an upcoming European auction featuring surplus analytical and bioprocessing equipment from a leading pharmaceutical manufacturer in the Netherlands.
Across Europe’s life sciences and bioprocessing sector, manufacturers are facing a familiar challenge: how to efficiently manage surplus laboratory and production assets while maintaining compliance, recovering value, and minimizing internal disruption. As facilities evolve, research priorities shift, and technologies advance, idle equipment can quickly become a logistical and financial burden.
EquipNet works with leading pharmaceutical, biotech, and life sciences organizations across Europe to address these challenges through structured surplus asset management programs. By combining local expertise with a global buyer network, EquipNet enables manufacturers to redeploy, sell, or consign surplus equipment in a way that aligns with operational, financial, and sustainability goals.
From Facility Transitions to Targeted Equipment Sales
EquipNet supports a wide range of surplus scenarios, from full facility closures to surplus to ongoing operations, helping organizations move assets offsite efficiently while maintaining transparency and control throughout the process. Services include coordinated logistics, secure warehousing, cataloging, global marketing, and multiple sales channels including negotiated sales, consignment, and online auctions.
A recent example of this approach is an upcoming European auction featuring surplus analytical and bioprocessing equipment from a leading pharmaceutical manufacturer in the Netherlands.
Online Auction: February 17–19, 2026
European Life Sciences & Bioprocessing Equipment Auction
EquipNet is currently hosting the European Life Sciences & Bioprocessing Equipment Auction, showcasing high-quality surplus equipment from major global manufacturers, including Beckman Coulter, GEA Westfalia, GE Healthcare, Waters, Pall, Shimadzu, and Thermo Scientific.
The auction includes a broad selection of equipment commonly used in pharmaceutical and biotech environments, such as:
- Chromatography and UPLC/HPLC systems
- Ultracentrifuges and separation equipment
- AKTA systems and bioprocessing tools
- Octet systems for biomolecular analysis
- Spectroscopy and mass spectrometry platforms
The full catalog is available now, allowing buyers to review detailed specifications ahead of bidding: Click here to view full lot catalog.
Key Auction Details:
- Auction Dates: 17–19 February 2026
- Equipment Location: Netherlands & Belgium
- Final Removal Date: April 1, 2026 (no exceptions)
By consolidating these assets into a single event, EquipNet enables sellers to reach a global audience while providing buyers access to late-model equipment from trusted manufacturers.
Turning Your Idle Assets into Opportunity
Beyond individual auctions, EquipNet partners with manufacturers across Europe to develop surplus strategies that fit their specific needs. Organizations with idle equipment, whether a single instrument, a group of assets, or an entire facility, can consign items into EquipNet’s global warehouses for upcoming auctions or pursue negotiated, private treaty sales with qualified buyers to maximize returns.
This flexible approach allows companies to:
- Free up valuable lab and production space
- Recover value from underutilized assets
- Reduce internal workload related to surplus management
- Maintain compliance and traceability throughout the disposition process
- Contribute to their company’s sustainability goals
With a global footprint and local coverage across Europe, EquipNet supports manufacturers at every stage of the asset lifecycle, helping ensure surplus equipment is managed efficiently, responsibly, and with maximum return.
For organizations evaluating how to handle idle or surplus equipment, EquipNet provides a proven pathway from inventory to outcome.
Contact details
- Contact person: EquipNet Auctions
- Email: [email protected]
- Webpage: https://www.equipnet.com/auctions/analytical/1548/?utm_source=lifesciencenetwork&utm_medium=newsarticle&utm_campaign=jjeurope021926
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1886
- Comments 0
Image 1
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Image 8
Image 9
Image 10
Image 11
Image 12
Image 13
Image 14
Image 15
Image 16
Image 17
Image 18
Image 19